dihexa administration Buy 15mg | Third-Party Tested DIHEXA | Peptide Synthetic |

Solution : Start with 250mcg minimum

Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP1 and amylin analogues owenhaskins Dec 19, 2025 2 min read Novo Nordisk has submitted a New Drug Application (NDA) to the FDA for once-weekly CagriSema (cagrilintide 2.4 mg and semaglutide 2.4 mg) injection, to be used with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity or overweight in the presence of at least one weight-related comorbid condition

It is frequently investigated for its cytoprotective effects and ability to support recovery across various tissue types

Discovered in the 1970s, DSIP is found in cerebrospinal fluid (CSF) in the brain and plasma, and its key role lies in modulating sleep patterns